Find Federal Grants
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
National Institutes of Health · PAR-19-356
National Institutes of Health · PAR-19-354
Ethiopia USAID-Addis Ababa · 72066319RFA00005
Health Resources and Services Administration · HRSA-20-087
Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER)
Malawi USAID-Lilongwe · 72061219RFA00005
Office of National Drug Control Policy · COOCLI1
Senegal USAID-Dakar · 72068519RFA00008
Service Area Competition
Health Resources and Services Administration · HRSA-20-019
Centers for Disease Control - ATSDR · CDC-RFA-TS20-2001
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-351
Health Resources and Services Administration · HRSA-20-024
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
National Institutes of Health · PAR-19-350
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
National Institutes of Health · PAR-19-348
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-347
National Institutes of Health · PAR-19-349
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-346
National Institutes of Health · PAR-19-345
Hazardous Materials Worker Health and Safety Training (U45 Clinical Trial Not Allowed)
National Institutes of Health · RFA-ES-19-003
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-343
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
National Institutes of Health · RFA-HL-20-030